Archives: Press Releases

Baltimore, MD and Frederick, MD: Founder City, an impactful, hybrid conference-event created in collaboration by Betamore and Frederick Innovative Technology Center, Inc. (FITCI) has expanded its weekly programming and is extending its pitch competition deadline, … Read more

Frederick MD – There’s been a lot of buzz about cryptocurrency, Bitcoin, and NFTs (non-fungible tokens) these days, and even small, mainstream investors are taking note, but one Maryland startup … Read more

Frederick, MD., May 5, 2021 — BioSolution Designs, LLC, announces that initial Seed Round goals are met and full operation begins as of May 1. BSD Founder and President, Dr. Thomas Reed, will direct … Read more

Frederick, MD: Santhanalakshmi Shanmugam appreciates the unique challenges women face when entering the workforce, especially in the demanding fields of science and technology. She founded Minnodi, LLC, a Maryland-based Women Owned Business focusing … Read more

Baltimore, MD and Frederick, MD: Betamore and Frederick Innovative Technology Center, Inc. (FITCI) have announced their collaboration on a new, more impactful, hybrid conference event, Founder City. Founder City brings together into … Read more

Goes, Netherlands, March 31, 2021 — Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that Aruba’s Laboratorio di Servicio (LdS) has validated and implemented NextGenPCR for SARS-CoV-2 testing. … Read more

Frederick, MD (March 17, 2021) – M Power Education, a Frederick-based e-learning and career training company, has experienced an explosive growth in the past year, despite the global pandemic. The company … Read more

FREDERICK, Md – January 26, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced that the … Read more

FREDERICK, Md – January 12, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted … Read more

Frederick, MD, November 2020 – ReVacc Biotech scientists have designed a multivalent nanoparticle vaccine candidate REVC-128 targeting the current predominant SARS-CoV-2 viral strain with D614G mutation. The preliminary immunogenicity study showed … Read more